Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence

An alternative promoter producing a novel 5′‐untranslated region of cannabinoid receptor mRNA has recently been described in CNR1, the gene encoding the cannabinoid receptor protein. Single nucleotide polymorphisms (SNPs) adjacent to this site were reported to be associated with polysubstance abuse [Zhang et al., 2004 ]. We examined the association of 4 SNPs (rs6928499, rs806379, rs1535255, rs2023239) in the distal region of intron 2 of CNR1 both with individual substance dependence diagnoses (i.e., alcohol, cocaine, and opioids), as well as with polysubstance dependence. The study samples consisted of European‐American (EA) and African‐American (AA) subjects with drug and or alcohol dependence (n = 895), and controls (n = 472). Subjects were grouped as polysubstance dependent, opioid dependent, cocaine dependent, cannabis dependent, and alcohol dependent. There was a modest association of marker rs1535255 with alcohol dependence (P = 0.04), though with correction for multiple phenotype comparisons, this effect was not considered statistically significant. These findings fail to replicate the original report of an association between SNPs adjacent to an alternative CNR1 exon 3 transcription start site and polysubstance abuse. © 2006 Wiley‐Liss, Inc.

[1]  Alisha R Pollastri,et al.  Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). , 2005, Drug and alcohol dependence.

[2]  V. Hesselbrock,et al.  Genomewide linkage scan for cocaine dependence and related traits: Significant linkages for a cocaine‐related trait and cocaine‐induced paranoia , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[3]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[4]  G. Uhl,et al.  Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse , 2004, Molecular Psychiatry.

[5]  J. Gelernter,et al.  Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence , 2001, Molecular Psychiatry.

[6]  D. Heller,et al.  The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users , 2001, Addiction biology.

[7]  D. Collier,et al.  No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population , 2000, Molecular Psychiatry.

[8]  M. Bleavins,et al.  High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes. , 1999, Molecular pathology : MP.

[9]  D. Comings,et al.  Cannabinoid receptor gene (CNR1): association with IV drug use , 1997, Molecular Psychiatry.

[10]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[11]  B. Martin,et al.  Neurobiology of marijuana abuse. , 1992, Trends in pharmacological sciences.

[12]  T. Bonner,et al.  Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15. , 1991, The New biologist.

[13]  R. Pertwee The central neuropharmacology of psychotropic cannabinoids. , 1988, Pharmacology & therapeutics.

[14]  L E Hollister,et al.  Health aspects of cannabis. , 1986, Pharmacological reviews.

[15]  W. Dewey Cannabinoid pharmacology. , 1986, Pharmacological reviews.